Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2006

View Archived Issues

T-817MA protects neurons by activated PKC epsilon

BrainCells to find new CNS applications for Organon compounds

Orexo and Doxa collaborate on drugs with unique delivery technology

NOV-002 for ARS procurement no longer considered by HHS

Cardio Vascu-Grow studied in peripheral artery disease

ABT-279: Abbott's new selective and safe DPP-IV inhibitor

Sun Pharma's lead antiallergic molecule begins phase II in the U.S.

Amylin to study neurohormones used in combination to treat obesity

Preclinical advance for ChronVac-C administered using MedPulser delivery system

Positive preclinical data for Ampligen combined with H5N1 vaccine

Apadenoson begins phase Ib study

Enrollment placed on hold in phase IIb/III study of desmoteplase for stroke

Topical local anesthetic 1207 begins clinical testing

MKC-1 studied in combination with pemetrexed for NSCLC

TNX-650 studied for asthma in phase I

Pharmos closes acquisition of Vela Pharmaceuticals

New data support use of Xience V stent in diabetic patients

New phase I/II trial studies MGC-D0103 in combination with Gemzar

Japanese approval for Sonazoid ultrasound contrast medium

IS-811: selective CCR3 antagonist with potential in asthma therapy

Novel antiarthritic agents recently patented

Novel P2Y12 receptor antagonists emerge from Pfizer R&D

Recent patents disclose novel diagnostic agents

Preclinical studies show neuroprotective properties of ONO-2231 in animal models

Junovan filed for treatment of osteosarcoma

Gene variants linked to prostate cancer risk in African Americans

SSR-180711 could ameliorate negative symptoms of schizophrenia

Suven presents preclinical data on novel promising 5-HT6 receptor antagonists

Minocycline studied in clinical trial for multiple sclerosis / News in Context

Several large trials presented at International Society of Hypertension Meeting: Part I

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...